These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18264198)

  • 1. Human papilloma virus vaccines and their role in cancer prevention.
    Jones RW; Coughlan EP; Reid JS; Sykes P; Watson PD; Cook C
    N Z Med J; 2007 Nov; 120(1266):U2829. PubMed ID: 18264198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
    Calo WA; Brewer NT
    Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papilloma virus and cancer of the cervix: a challenge facing Nepal.
    Gilbert DC
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):396-7. PubMed ID: 18603941
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM; Kaldor JM; Garland SM
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination.
    Budd AC; Sturrock CJ
    Sex Health; 2010 Sep; 7(3):328-34. PubMed ID: 20719223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
    Van de Velde N; Boily MC; Drolet M; Franco EL; Mayrand MH; Kliewer EV; Coutlée F; Laprise JF; Malagón T; Brisson M
    J Natl Cancer Inst; 2012 Nov; 104(22):1712-23. PubMed ID: 23104323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expected impact of a quadrivalent HPV vaccine in France].
    Riethmuller D; Prétet JL; Denis F; Aubin F; Pradat P; Clavel C; Dachez R; Gondry J; Carcopino X; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):389-95. PubMed ID: 19481365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HPV immunization on the detection of cervical disease.
    Munro AJ; Cruickshank ME
    Expert Rev Vaccines; 2014 Apr; 13(4):533-44. PubMed ID: 24606579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.
    Brisson M; Van de Velde N; De Wals P; Boily MC
    CMAJ; 2007 Aug; 177(5):464-8. PubMed ID: 17709404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HPV vaccination in Germany Low vaccination rates endanger prevention goals].
    MMW Fortschr Med; 2009 Dec; 151(51-52):44-5. PubMed ID: 20088323
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal immunisation with human papillomavirus (HPV) vaccine among females aged 12-17 recommended in Germany.
    Deleré Y; Meyer C; Reiter S
    Euro Surveill; 2007 Apr; 12(4):E070405.2. PubMed ID: 17439800
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccination--more answers, more questions.
    Sawaya GF; Smith-McCune K
    N Engl J Med; 2007 May; 356(19):1991-3. PubMed ID: 17494933
    [No Abstract]   [Full Text] [Related]  

  • 16. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New viral vaccines for dermatologic disease.
    Urman CO; Gottlieb AB
    J Am Acad Dermatol; 2008 Mar; 58(3):361-70. PubMed ID: 18280332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population impact of HPV vaccines: summary of early evidence.
    Hariri S; Markowitz LE; Dunne EF; Unger ER
    J Adolesc Health; 2013 Dec; 53(6):679-82. PubMed ID: 24263069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer: problem solved? Vaccinating girls against human papillomavirus.
    Crosbie EJ; Brabin L
    BJOG; 2010 Jan; 117(2):137-42. PubMed ID: 20050177
    [No Abstract]   [Full Text] [Related]  

  • 20. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.
    Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G
    Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.